Brian D. Gildea
Corporate Officer/Principal bij Boston University Office of Technology Development
Actieve functies van Brian D. Gildea
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Boston University Office of Technology Development
Boston University Office of Technology Development Investment ManagersFinance The Boston University Office of Technology Development invests through the Boston University Technology Fund. The Fund provides venture capital and access to Boston University's scientific and technical resources for promising companies | Corporate Officer/Principal | 27-12-2011 | - |
Private Equity Investor | 22-07-2010 | 27-12-2011 |
Loopbaan van Brian D. Gildea
Eerdere bekende functies van Brian D. Gildea
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Boston Probes, Inc.
Boston Probes, Inc. Medical SpecialtiesHealth Technology Boston Probes, Inc. developed peptide nucleic acid probe-based systems for human cytogenetics. The company was founded by James M. Coull and Brian D. Gildea and was headquartered in Waltham, MA. | Oprichter | 01-01-1996 | - |
Applera Corp.
Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Corporate Officer/Principal | - | - |
Opleiding van Brian D. Gildea
Boston College | Graduate Degree |
Stonehill College, Inc. | Undergraduate Degree |
Suffolk University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Graduate Degree | 2 |
Corporate Officer/Principal | 2 |
Private Equity Investor | 1 |
Sectoraal
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Applera Corp.
Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Health Technology |
Boston Probes, Inc.
Boston Probes, Inc. Medical SpecialtiesHealth Technology Boston Probes, Inc. developed peptide nucleic acid probe-based systems for human cytogenetics. The company was founded by James M. Coull and Brian D. Gildea and was headquartered in Waltham, MA. | Health Technology |
Boston University Office of Technology Development
Boston University Office of Technology Development Investment ManagersFinance The Boston University Office of Technology Development invests through the Boston University Technology Fund. The Fund provides venture capital and access to Boston University's scientific and technical resources for promising companies | Finance |
- Beurs
- Insiders
- Brian D. Gildea
- Ervaring